Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza.

CTSW EPN2 TAILS cathepsin W cysteine protease cathepsin W epsin 2 host-directed antivirals influenza A virus influenza virus terminal amine isotopic labeling of substrates virus entry

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
31 08 2022
Historique:
pubmed: 23 7 2022
medline: 9 9 2022
entrez: 22 7 2022
Statut: ppublish

Résumé

Influenza A virus (IAV) coopts numerous host factors for efficient replication. The cysteine protease cathepsin W (CTSW) has been identified as one host factor required for IAV entry, specifically for the escape of IAVs from late endosomes. However, the substrate specificity of CTSW and the proviral mechanism are thus far unknown. Here, we show that intracellular but not secreted CTSW promotes viral entry. We reveal 79 potential direct and 31 potential indirect cellular target proteins of CTSW using the high-throughput proteomic approach terminal amine isotopic labeling of substrates (TAILS) and determine the cleavage motif shared by the substrates of CTSW. Subsequent integration with data from RNA interference (RNAi) screens for IAV host factors uncovers first insights into the proviral function of CTSW. Notably, CTSW-deficient mice display a 25% increase in survival and a delay in mortality compared to wild-type mice upon IAV infection. Altogether, these findings support the development of drugs targeting CTSW as novel host-directed antiviral therapies.

Identifiants

pubmed: 35867415
doi: 10.1128/spectrum.00921-22
pmc: PMC9431242
doi:

Substances chimiques

Antiviral Agents 0
CTSW protein, human EC 3.4.22.-
Cathepsin W EC 3.4.22.-
Ctsw protein, mouse EC 3.4.22.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0092122

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI135972
Pays : United States

Références

Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11790-5
pubmed: 18689690
Virology. 2006 Mar 15;346(2):251-7
pubmed: 16460775
Nature. 1998 Aug 20;394(6695):793-7
pubmed: 9723620
Int J Biochem Cell Biol. 2000 Mar;32(3):373-84
pubmed: 10716634
J Exp Med. 2021 Jun 7;218(6):
pubmed: 33882122
PLoS Pathog. 2011 Mar;7(3):e1001329
pubmed: 21483486
Science. 2005 Jun 10;308(5728):1643-5
pubmed: 15831716
J Infect Dis. 2007 Jul 15;196(2):249-57
pubmed: 17570112
Nat Protoc. 2011 Sep 22;6(10):1578-611
pubmed: 21959240
J Biol Chem. 1999 Nov 26;274(48):33959-65
pubmed: 10567358
Nat Methods. 2009 Nov;6(11):786-7
pubmed: 19876014
Arch Biochem Biophys. 2019 Jul 30;670:32-42
pubmed: 30807742
Microbes Infect. 2004 Aug;6(10):929-36
pubmed: 15310470
J Biol Chem. 1991 Sep 15;266(26):17707-12
pubmed: 1832676
Biochim Biophys Acta. 2012 Jan;1824(1):68-88
pubmed: 22024571
J Cell Biol. 1968 Dec;39(3):676-97
pubmed: 5699937
Antivir Ther. 2012;17(1 Pt B):159-73
pubmed: 22311680
mSphere. 2020 Aug 26;5(4):
pubmed: 32848003
Nat Struct Mol Biol. 2004 Jun;11(6):567-73
pubmed: 15122347
J Biol Chem. 2012 Oct 5;287(41):34455-64
pubmed: 22893708
mBio. 2015 Jun 09;6(3):e00297
pubmed: 26060270
Curr Opin Microbiol. 2015 Aug;26:79-88
pubmed: 26112615
Front Pharmacol. 2016 Apr 25;7:107
pubmed: 27199750
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81
pubmed: 16081529
Virology. 1985 Jun;143(2):651-6
pubmed: 2414912
J Biol Chem. 2004 Jun 25;279(26):27525-33
pubmed: 15087452
Nat Biotechnol. 2008 Jun;26(6):685-94
pubmed: 18500335
Mol Cell. 2012 Jun 8;46(5):674-90
pubmed: 22681889
J Virol. 2005 Oct;79(20):12714-20
pubmed: 16188974
Int J Biochem Cell Biol. 2007;39(10):1765-70
pubmed: 17276129
Annu Rev Med. 2020 Jan 27;71:315-327
pubmed: 31600454
Nature. 2010 Feb 11;463(7282):813-7
pubmed: 20027183
Cells. 2019 Mar 20;8(3):
pubmed: 30897858
Curr Opin Virol. 2015 Oct;14:71-8
pubmed: 26364134
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
J Gen Virol. 2014 Feb;95(Pt 2):263-277
pubmed: 24225499
Nat Biotechnol. 2001 Jul;19(7):661-7
pubmed: 11433279
Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62
pubmed: 6035483
Cell Host Microbe. 2015 Dec 9;18(6):723-35
pubmed: 26651948

Auteurs

Sira C Günther (SC)

Institute of Medical Virology, University of Zurichgrid.7400.3, Zurich, Switzerland.
Life Science Zurich Graduate School, ETH and University of Zurichgrid.7400.3, Zurich, Switzerland.

Carles Martínez-Romero (C)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Milagros Sempere Borau (M)

Institute of Medical Virology, University of Zurichgrid.7400.3, Zurich, Switzerland.
Life Science Zurich Graduate School, ETH and University of Zurichgrid.7400.3, Zurich, Switzerland.

Christine T N Pham (CTN)

Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri, USA.

Adolfo García-Sastre (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Silke Stertz (S)

Institute of Medical Virology, University of Zurichgrid.7400.3, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH